Penicillin Allergy Decision and Mobile Empowerment (PADME) is a penicillin (PCN) allergy delabeling program that utilizes a patient-initiated risk assessment survey and leverages telehealth and community partners to reduce disparities in access to PCN allergy delabeling. The PADME website was recently updated to include a free patient-facing adult survey to assess risk of true allergy to PCN. Previously, the PCN allergy risk survey offered on their site was limited to pediatric patients. Along with the addition of the adult survey, the PADME website is now available in Spanish, in an effort to reach the growing patient population for PCN allergy.
The implementation of this important addition to the PADME website was led by Dr. Mildred Kwan, Associate Professor of Medicine and Director of Quality Improvement in the 黑料网 Division of Rheumatology, Allergy & Immunology, in collaboration with Dr. Andrew Winslow, former 黑料网 Allergy and Immunology fellow and current Pediatric Allergist and Assistant Professor in the University of Cincinnati Division of Allergy and Immunology, and Dr. Nonie Arora, second year 黑料网 Allergy and Immunology fellow. The 黑料网 Connected Health for Applications & Interventions (CHAI) Core and Lineberger Cancer Center served as essential resources for this project, with special thanks from Dr. Kwan to Brittany Frew for her management of the project.
To access this tool, visit the PADME website () and to learn more about PADME, read the published papers listed below.
Nonie Arora, Mildred Kwan, Andrew Winslow. Penicillin Allergy Decision and Mobile Empowerment (PADME): Patient engagement and delabeling outcomes. Journal of Allergy and Clinical Immunology. Volume 155, Issue 2, Supplement, 2025, Page AB184. ISSN 0091-6749.
Andrew Winslow, Mildred Kwan. Penicillin Allergy Decision and Mobile Empowerment (PADME): A Novel Patient-Initiated Delabeling Program. Journal of Allergy and Clinical Immunology. Volume 153, Issue 2, Supplement, 2024, Page AB131. ISSN 0091-6749.